Breakdown | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 16.55B | 8.64B | 3.91B | 1.33B | 376.03M |
Gross Profit | 12.02B | 6.59B | 3.11B | 1.03B | 259.18M |
EBITDA | 8.46B | 4.61B | 2.10B | 563.14M | 6.70M |
Net Income | 5.79B | 2.65B | 1.33B | 368.16M | 4.25M |
Balance Sheet | |||||
Total Assets | 12.00B | 8.33B | 4.23B | 1.35B | 617.87M |
Cash, Cash Equivalents and Short-Term Investments | 10.17B | 7.43B | 3.98B | 1.18B | 555.97M |
Total Debt | 58.76M | 101.71M | 136.30M | 150.06M | 145.00M |
Total Liabilities | 2.98B | 2.73B | 1.30B | 575.81M | 208.26M |
Stockholders Equity | 9.02B | 5.60B | 2.93B | 777.77M | 409.61M |
Cash Flow | |||||
Free Cash Flow | 5.32B | 3.90B | 2.06B | 653.47M | 12.04M |
Operating Cash Flow | 5.48B | 3.96B | 2.08B | 678.97M | 15.88M |
Investing Cash Flow | -308.34M | -400.20M | -79.29M | -57.29M | -34.29M |
Financing Cash Flow | -2.43B | -110.48M | 804.89M | -347.00K | 443.92M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥75.81B | 17.05 | 2.28% | 5.21% | -13.86% | ||
77 Outperform | $251.57B | 20.79 | 27.55% | 1.97% | 4.43% | 10.63% | |
76 Outperform | ¥80.25B | 24.66 | ― | 1.98% | -32.01% | ||
76 Outperform | ¥94.04B | 14.71 | 1.34% | 54.92% | 172.49% | ||
58 Neutral | HK$93.21B | 5.42 | -3.19% | 4.97% | 5.93% | -50.48% |
M&A Research Institute Holdings Inc. has repurchased 1,267,500 of its own common shares for 1,652,415,800 yen through market purchases on the Tokyo Stock Exchange during July 2025. This repurchase is part of a broader initiative approved by the Board of Directors to buy back up to 7,500,000 shares, indicating a strategic move to consolidate ownership and potentially enhance shareholder value.
The most recent analyst rating on (JP:9552) stock is a Buy with a Yen6300.00 price target. To see the full list of analyst forecasts on M&A Research Institute Holdings Inc. stock, see the JP:9552 Stock Forecast page.
M&A Research Institute Holdings Inc. reported a significant decline in its financial performance for the nine months ending June 30, 2025, with net sales and profits dropping substantially compared to the previous year. The company’s operating profit decreased by 53.8%, and the profit attributable to owners fell by 57.5%. Despite this downturn, the company has expanded its consolidation scope by including two new subsidiaries, potentially positioning itself for future growth.
The most recent analyst rating on (JP:9552) stock is a Buy with a Yen6300.00 price target. To see the full list of analyst forecasts on M&A Research Institute Holdings Inc. stock, see the JP:9552 Stock Forecast page.
M&A Research Institute Holdings Inc. has announced the repurchase of 1,251,200 of its common shares, amounting to 1,646,840,400 yen, conducted through market purchases on the Tokyo Stock Exchange from June 1 to June 30, 2025. This move is part of a broader strategy authorized by the Board of Directors to repurchase up to 7,500,000 shares, aiming to enhance shareholder value and optimize capital structure, reflecting the company’s commitment to strategic financial management.
The most recent analyst rating on (JP:9552) stock is a Buy with a Yen6300.00 price target. To see the full list of analyst forecasts on M&A Research Institute Holdings Inc. stock, see the JP:9552 Stock Forecast page.
M&A Research Institute Holdings Inc. has announced that its stock has been selected as a Loan Margin Trading Issue on the Tokyo Stock Exchange Prime Market, effective June 24, 2025. This designation is expected to enhance the liquidity and supply-demand balance of the company’s stock, promoting active trading and fair pricing.
The most recent analyst rating on (JP:9552) stock is a Buy with a Yen6300.00 price target. To see the full list of analyst forecasts on M&A Research Institute Holdings Inc. stock, see the JP:9552 Stock Forecast page.